Log in

Bioanalytical Systems Stock Forecast, Price & News

-0.11 (-2.16 %)
(As of 10/30/2020 12:00 AM ET)
Today's Range
Now: $4.98
50-Day Range
MA: $5.02
52-Week Range
Now: $4.98
Volume6,419 shs
Average Volume18,116 shs
Market Capitalization$54.73 million
P/E RatioN/A
Dividend YieldN/A
Bioanalytical Systems, Inc., doing business as Inotiv, a pharmaceutical development company, provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment also provides in vivo sampling services for the continuous monitoring of chemical changes in life; non-clinical toxicology and pathology services; analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; and climate-controlled archiving services for its customers' data and samples. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.06 out of 5 stars

Industry, Sector and Symbol

Industry Commercial physical research
Current SymbolNASDAQ:BASI



Sales & Book Value

Annual Sales$43.62 million
Cash Flow$0.21 per share
Book Value$1.02 per share


Net Income$-790,000.00


Market Cap$54.73 million
Next Earnings Date12/28/2020 (Estimated)
OptionableNot Optionable
-0.11 (-2.16 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BASI News and Ratings via Email

Sign-up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Bioanalytical Systems (NASDAQ:BASI) Frequently Asked Questions

How has Bioanalytical Systems' stock price been impacted by COVID-19?

Bioanalytical Systems' stock was trading at $4.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BASI stock has increased by 15.5% and is now trading at $4.98.
View which stocks have been most impacted by COVID-19

When is Bioanalytical Systems' next earnings date?

Bioanalytical Systems is scheduled to release its next quarterly earnings announcement on Monday, December 28th 2020.
View our earnings forecast for Bioanalytical Systems

How were Bioanalytical Systems' earnings last quarter?

Bioanalytical Systems, Inc. (NASDAQ:BASI) posted its quarterly earnings results on Friday, August, 14th. The company reported ($0.08) EPS for the quarter. The company had revenue of $15.77 million for the quarter. Bioanalytical Systems had a negative return on equity of 17.25% and a negative net margin of 4.38%.
View Bioanalytical Systems' earnings history

Who are some of Bioanalytical Systems' key competitors?

What other stocks do shareholders of Bioanalytical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioanalytical Systems investors own include Riot Blockchain (RIOT), The Boeing (BA), NVIDIA (NVDA), Overstock.com (OSTK), Enphase Energy (ENPH), Pure Storage (PSTG), Mastercard (MA), Main Street Capital (MAIN), QUALCOMM (QCOM) and Toll Brothers (TOL).

Who are Bioanalytical Systems' key executives?

Bioanalytical Systems' management team includes the following people:
  • Mr. Robert W. Leasure Jr., Pres, CEO & Director (Age 60, Pay $364.86k)
  • Mr. Daniel Thomas Oakley, Chief Operations Officer (Age 62, Pay $407.5k)
  • Dr. John E. Sagartz D.V.M., DiplomateACVP, DVM, Ph.D., Chief Strategy Officer & Director (Age 55, Pay $265k)
  • Dr. Peter T. Kissinger, Founder, Chairman Emeritus & Scientific Advisor (Age 75)
  • Ms. Beth A. Taylor CPA, CFO & VP of Fin. (Age 55)

What is Bioanalytical Systems' stock symbol?

Bioanalytical Systems trades on the NASDAQ under the ticker symbol "BASI."

How do I buy shares of Bioanalytical Systems?

Shares of BASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bioanalytical Systems' stock price today?

One share of BASI stock can currently be purchased for approximately $4.98.

How big of a company is Bioanalytical Systems?

Bioanalytical Systems has a market capitalization of $54.73 million and generates $43.62 million in revenue each year. Bioanalytical Systems employs 311 workers across the globe.

What is Bioanalytical Systems' official website?

The official website for Bioanalytical Systems is www.basinc.com.

How can I contact Bioanalytical Systems?

Bioanalytical Systems' mailing address is 2701 KENT AVENUE, WEST LAFAYETTE IN, 47906. The company can be reached via phone at 765-463-4527 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.